| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5734231 | Journal of Surgical Research | 2017 | 12 Pages |
Abstract
CCL22 plays an important role in supporting gastric cancer development presumably by increasing the percentage of regulatory T cells in the tumor microenvironments. CCL22 levels in sera have a predictive value for gastric cancer peritoneal metastasis and the early recurrence. Therefore, CCL22 may be a therapeutic target for gastric cancer.
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
Yuzhe MD, Tie MD, PhD, Hongjiang MD, PhD, Lining MD, MSc, Gongwei MD, Lei MD, Yingwei MD, PhD,